معرفی
Junio Dort is an Assistant Professor at the University of Ottawa's School of Pharmaceutical Sciences, with cross-appointments in the Department of Biochemistry, Microbiology and Immunology and the Department of Cellular and Molecular Medicine. He earned his BSc in Food Sciences from Université d’État d’Haiti (2007), an MSc from Université Catholique de Louvain (2009), and a PhD in Nutrition from Laval University (2014). His postdoctoral training at CHU Sainte-Justine Research Center (2022) focused on therapeutic compounds targeting inflammation and muscle stem cell dysfunction in muscular dystrophies.
- BSc, Food Sciences, Université d’État d’Haiti, 2007
- MSc, Food Sciences, Université Catholique de Louvain, 2009
- PhD, Nutrition, Laval University, 2014
Dr. Dort’s research centers on muscle regeneration, pharmacotherapy, and bioactive lipid mediators, particularly in the context of muscular dystrophies. His work explores the role of compounds like Resolvin-D2 and GPR18 agonists in modulating inflammation, enhancing myogenesis, and restoring muscle function. He also investigates the interplay between muscle stem cell identity and therapeutic potential, especially through PRMT inhibition and adhesion receptors like Gpr116.
Recent publications highlight trends in muscle regeneration pharmacology, including bioactive lipids, PRMT inhibitors, and vascular niche stimulation via apelin. His studies span Duchenne muscular dystrophy models, postnatal muscle development, and molecular mechanisms underlying fiber type determination.
- Development grant (2021-2024), Muscular Dystrophy Association
- Postdoctoral fellowship (2020-2022), French Muscular Dystrophy Association
- Postdoctoral fellowship for excellence (2017-2019), Sainte-Justine Foundation
- Doctoral award (2009-2011), Organization of American States
- Master award (2008-2009), University Commission for Development, Belgium
Dr. Dort’s lab at CHU Sainte-Justine Research Center, under Dr. Nicolas Dumont, investigates inflammation-targeting therapies for muscular dystrophies. His cross-appointments reflect interdisciplinary collaborations in regenerative medicine and nutrition science.
